ArticleNature communications2024

A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancer.

Buse Eglenen-Polat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.